With the expansion of Indian economy, the new wave of globalization also left its mark in India where new business ventures and various opportunities appeared for Indian businessmen. Hence, in 1991, various reforms appeared which were initiated by government in order to facilitate business and trade development (Sawhney, 2004)
This term covers the efforts undertaken by the business towards sustainable economic development (Holme & Watts, 2006). CSR initiatives seek to establish businesses as good corporate citizens in the society (Sagar & Singla, 2004)
The multifaceted presence of religious ideologies in the Indian culture gives the CSR practices in Indian industry a spiritual outlook instead of a realistic business practice. Hence, the idea is to give preference to salvation over worldly gains and urges to attain profit (Sharma & Talwar, 2005)
The multifaceted presence of religious ideologies in the Indian culture gives the CSR practices in Indian industry a spiritual outlook instead of a realistic business practice. Hence, the idea is to give preference to salvation over worldly gains and urges to attain profit (Sharma & Talwar, 2005)
The multifaceted presence of religious ideologies in the Indian culture gives the CSR practices in Indian industry a spiritual outlook instead of a realistic business practice. Hence, the idea is to give preference to salvation over worldly gains and urges to attain profit (Sharma & Talwar, 2005)
Since it was the time of growth and development, the industry faced a competition in attracting the suitable talent. Therefore, employee retention and employee development practices were initiated by many corporations in order retain their talent (Sundar, 2008)
Even the ecosystem of the same locality is highly unsuitable for animals, plants and humans. The inhabitants of this region have appeared to be highly affected by the disaster that took place in 1984 (Tinsley & Anseley, 2011)
He concludes by highlighting the positive consequences of such CSR activities, especially in regards to the treatment of AIDS patients. Unichem, an Indian pharmaceutical company, carries out several CSR activities including the conduction of blood donation drives, tree plantation drives, provision of medical assistance to employees and their families, and arrangement of knowledge session such as seminars and trainings for employees (Unichem Laboratories Ltd., 2009)
The numerous corporate ambiguities those are inherent in business decisions regarding marring CSR initiatives with the business initiatives. Thus, any CSR activity which is strategic should be close to the mission and vision of the organization (Yeoh, 2007; Du et al
The Medicare discussion presented in the book is also timely and important. Medicare, supplemented by Medicaid, provides access to health insurance coverage for more than 45 million people who qualify due to disability or age (Aaron, 2011)
For example, in one chapter a Texas family discovered that seeking care for their son's cerebral palsy was hampered by policies, lengthy waits, and ambiguity. Even more unsettling, are accounts of how those with mental illness are treated, the inadequacies of employer-based coverage, reductions in charity care, and also overburdened hospital systems (Cohen, 2007)
I was particularly taken with the pre-existing condition dilemma presented in the book and how this affects so many families -- particularly those who are elderly or families of small children with debilitating illnesses. Conditions from cancer to heart disease to chronic asthma to HIV / AIDS can create massive healthcare costs and yet, under the current system of things, those who fall into these categories are most likely to be unable to receive the care they so desperately need because insurance companies can be biased (Deinard, & Russell, 2011)
Most organizations and state legislatures have been challenged to support health programs at the required level while contending with declining revenues (Goodman, 1991). There are tough questions about how insurers, pharmaceutical organizations, and the government can collaborate and work in harmony with shifting agendas and strategies (Gardner, 2012)
Conclusions that impact or healthcare system and/or the pharmaceutical industry Indeed, recent years have revealed an overall detrimental decline in many areas of the health care system. Most organizations and state legislatures have been challenged to support health programs at the required level while contending with declining revenues (Goodman, 1991)
Meaningful comparison of drug prices in different countries is technically problematic, because of vast differences in the range of drugs, forms, strengths and pack sizes available in different countries." (Danizon, 2002) Do they have an efficient amount of resources? Some would contend that the industry has, if anything, too many resources, not simply economically, but also in congress
Public Health Concerns The most fundamental ethical problem in the modern pharmaceutical industry is simply that the objective of maximizing profit by private business organizations is inconsistent with and often directly at odds with the interests of public health, safety, and welfare. That fundamental problem does manifest itself through the decisions and actions of isolated individuals; rather, it is a problem that permeates the entire mindset and approach to business throughout the pharmaceutical industry (Beauchamp & Childress, 2009; Santoro & Gorrie, 2005)
Consumer goods are manufactured abroad at a very small fraction of the cost of producing the same product domestically and then sold domestically at a tremendously increased profit margin. Within the pharmaceutical industry, the process is reversed: pharmaceutical products developed in the wealthiest nations are marketed to the populations of the poorest nations largely free from the many restrictions and safety requirements imposed domestically to govern their sale and consumption for the express purpose of ensuring patient health, safety, and welfare (Halbert & Ingulli, 2009; Santoro & Gorrie, 2005)
In fact, a comprehensive solution will require the combined efforts of pharmaceutical companies, government legislators, industry regulators, private review boards, public welfare advocacy groups, representatives from both medical and scientific communities, and of national and international research-funding agencies. The Pharmaceutical Product Development Process since the 1960s When it comes to the business of pharmaceutical development, testing, and use, ethical issues are framed by no less than three independent industries, each with different sets of concerns and criteria: namely, those of the medical community, the scientific research community, and those of business organizations (Santoro & Gorrie, 2005; Tong, 2007)
federal prohibition of funding for crucial human stem cell therapy-based research during the Clinton administration was a result of the direct influence of pharmaceutical industry lobbyists responding to the potential threat from non-pharmaceutical treatments for diseases that generate billions of dollars in revenue annually for that industry (Santoro & Gorrie, 2005). In essence, it was one of many examples whereby the powerful corporate lobbyists and their hired technical experts managed to successfully persuade legislators on matters where their respective comprehension of the issues differed greatly and where the former achieved their goals by a combination of "incentives" and obfuscation of relevant issues that lawmakers are ill-equipped to decide based on their lack of fundamental understanding of the merits of the scientific arguments (Tong, 2007)
Outsourcing has been found to decrease the time from discovery to market (Coulson & Kleiner, 2008). The outsourcing of pharmaceutical activities to other countries has raised concerns over security, privacy, and human rights issues in the industry (Aruru & Salmon, 2008)